RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

80 hedge funds and large institutions have $301M invested in Revance Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 19 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$27.1M
2 +$7.01M
3 +$3.98M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$3.69M
5
JP Morgan Chase
JP Morgan Chase
New York
+$3M
Name Holding Trade Value Shares
Change
Change in
Stake
101
102
103
104
105
106
107